| scholarly article | Q13442814 |
| P2093 | author name string | Friedemann Weber | |
| Michele Bouloy | |||
| P2860 | cites work | New vectors of Rift Valley fever in West Africa | Q24273388 |
| The S Segment of Punta Toro Virus (Bunyaviridae, Phlebovirus) Is a Major Determinant of Lethality in the Syrian Hamster and Codes for a Type I Interferon Antagonist | Q27478045 | ||
| La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts | Q27480353 | ||
| A Shared Transcription Termination Signal on Negative and Ambisense RNA Genome Segments of Rift Valley Fever, Sandfly Fever Sicilian, and Toscana Viruses | Q27480356 | ||
| The Cytoplasmic Tails of Uukuniemi Virus (Bunyaviridae) GN and GC Glycoproteins Are Important for Intracellular Targeting and the Budding of Virus-Like Particles | Q27481505 | ||
| Emerging viruses: the Bunyaviridae | Q27485354 | ||
| Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus | Q27485488 | ||
| The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection | Q27485926 | ||
| Host-derived 5' ends and overlapping complementary 3' ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus | Q27486545 | ||
| Uukuniemi virus S RNA segment: ambisense coding strategy, packaging of complementary strands into virions, and homology to members of the genus Phlebovirus | Q27486556 | ||
| Interferon-inducible antiviral effectors | Q27486790 | ||
| Three-Dimensional Organization of Rift Valley Fever Virus Revealed by Cryoelectron Tomography | Q27487138 | ||
| RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses | Q27487321 | ||
| Single-particle cryo-electron microscopy of Rift Valley fever virus | Q27488344 | ||
| RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates | Q27861007 | ||
| 5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
| Modulation of YY1 activity by SAP30 | Q28176911 | ||
| Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance | Q30233476 | ||
| TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. | Q33198557 | ||
| Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response | Q33278262 | ||
| A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. | Q33316823 | ||
| Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation | Q33406230 | ||
| Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines | Q33570326 | ||
| ??? | Q60032360 | ||
| Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system | Q33755025 | ||
| Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. | Q33911860 | ||
| Surface structure of Uukuniemi virus | Q34053534 | ||
| Hemorrhagic fever viruses as biological weapons: medical and public health management | Q34126496 | ||
| Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis | Q34625091 | ||
| Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. | Q34755987 | ||
| Rift Valley fever virus | Q34971963 | ||
| Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. | Q35000433 | ||
| NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. | Q35024013 | ||
| Rift Valley fever: an uninvited zoonosis in the Arabian peninsula | Q35077306 | ||
| Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle | Q35702918 | ||
| NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis | Q36315241 | ||
| Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals | Q36484009 | ||
| Bunyavirus RNA Synthesis: Genome Transcription and Replication | Q36527426 | ||
| Ribonucleoproteins of Uukuniemi virus are circular | Q36531460 | ||
| Segmented genome and nucleocapsid of La Crosse virus | Q36549527 | ||
| Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins. | Q36797004 | ||
| La Crosse virions contain a primer-stimulated RNA polymerase and a methylated cap-dependent endonuclease. | Q36894820 | ||
| Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya | Q37009607 | ||
| Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs | Q37095192 | ||
| Development of a RVFV ELISA that can distinguish infected from vaccinated animals | Q37321966 | ||
| Rift valley fever vaccines | Q37393780 | ||
| Mapping the Golgi targeting and retention signal of Bunyamwera virus glycoproteins | Q37511527 | ||
| Rift Valley Fever Virus: Some Ultrastructural Observations on Material from the Outbreak in Egypt 1977 | Q38991879 | ||
| NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase | Q39195523 | ||
| Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter | Q39548682 | ||
| The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
| Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
| Hantavirus nucleocapsid protein oligomerization | Q39607249 | ||
| Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein | Q39686341 | ||
| Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. | Q39778891 | ||
| The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules | Q39870549 | ||
| Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses | Q39893246 | ||
| T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus | Q39946457 | ||
| NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription | Q39960501 | ||
| Characterization of Bunyamwera virus S RNA that is transcribed and replicated by the L protein expressed from recombinant vaccinia virus. | Q40044342 | ||
| Expression of functional Bunyamwera virus L protein by recombinant vaccinia viruses | Q40106211 | ||
| Isolation of the ends of La Crosse virus small RNA as a double-stranded structure. | Q40143706 | ||
| The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging | Q40182219 | ||
| Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins | Q40233812 | ||
| Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors | Q40237419 | ||
| Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis | Q40289172 | ||
| Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene | Q40311587 | ||
| Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers | Q40397884 | ||
| Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus | Q40399200 | ||
| Potential vectors of Rift Valley fever virus in the Mediterranean region | Q40414505 | ||
| Characterization of Rift Valley fever virus transcriptional terminations. | Q40448667 | ||
| Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease. | Q40453546 | ||
| Rift Valley fever outbreak--Kenya, November 2006-January 2007. | Q40458723 | ||
| Efficient bunyavirus rescue from cloned cDNA. | Q40487364 | ||
| Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus | Q40498246 | ||
| Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment | Q40499504 | ||
| The N terminus of Rift Valley fever virus nucleoprotein is essential for dimerization | Q40499509 | ||
| Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids | Q40655819 | ||
| Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment | Q40656673 | ||
| Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
| Rift Valley fever in rural northern Senegal: human risk factors and potential vectors. | Q40700580 | ||
| Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases | Q40700712 | ||
| Analysis of 3' and 5' ends of N and NSs messenger RNAs of Toscana Phlebovirus | Q40727382 | ||
| Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses | Q40752380 | ||
| Rift Valley fever virus M segment: cellular localization of M segment-encoded proteins | Q40783794 | ||
| Immunoelectron microscopy of Rift Valley fever viral morphogenesis in primary rat hepatocytes | Q40792421 | ||
| The Bunyamwera virus nonstructural protein NSs inhibits viral RNA synthesis in a minireplicon system | Q40823920 | ||
| Protein synthesis in Rift Valley fever virus-infected cells | Q40827849 | ||
| Characterization of the 5' and 3' ends of viral messenger RNAs isolated from BHK21 cells infected with Germiston virus (Bunyavirus). | Q41741525 | ||
| Homotypic interaction of Bunyamwera virus nucleocapsid protein | Q42279558 | ||
| Golgi localization of Hantaan virus glycoproteins requires coexpression of G1 and G2. | Q45731161 | ||
| Sin Nombre virus mRNA synthesis | Q45767384 | ||
| Panhandles and hairpin structures at the termini of germiston virus RNAs (Bunyavirus). | Q45792576 | ||
| Interaction between molecules of hantavirus nucleocapsid protein | Q60031969 | ||
| P921 | main subject | molecular biology | Q7202 |
| Rift Valley fever | Q326638 | ||
| Rift Valley fever virus | Q14276794 | ||
| Rift Valley fever phlebovirus | Q24809101 | ||
| P304 | page(s) | 8-14 | |
| P577 | publication date | 2010-04-22 | |
| P1433 | published in | The open virology journal | Q27722048 |
| P1476 | title | Molecular biology of rift valley Fever virus | |
| P478 | volume | 4 |
| Q62486031 | A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008-2010 |
| Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
| Q34244912 | AMP-activated kinase restricts Rift Valley fever virus infection by inhibiting fatty acid synthesis |
| Q34031858 | Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice |
| Q38748778 | Creation of a recombinant Rift Valley fever virus with a two-segmented genome |
| Q47556353 | Ecological distribution and population dynamics of Rift Valley fever virus mosquito vectors (Diptera, Culicidae) in Senegal |
| Q50329180 | Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination |
| Q35902010 | Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep. |
| Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
| Q61821360 | M segment-based minigenomes and virus-like particle assays as an approach to assess the potential of tick-borne Phlebovirus genome reassortment |
| Q33442499 | Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated the generation of NSs-deletant viruses |
| Q63707129 | Modeling the Tertiary Structure of the Rift Valley Fever Virus L Protein |
| Q40220077 | Molecular detection of Rift Valley fever virus in serum samples from selected areas of Tanzania |
| Q43167772 | Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach. |
| Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
| Q26314415 | RNA Encapsidation and Packaging in the Phleboviruses |
| Q33634293 | RNA Interference Restricts Rift Valley Fever Virus in Multiple Insect Systems |
| Q34320633 | RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila |
| Q38820203 | Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis |
| Q36127490 | Serum levels of inflammatory cytokines in Rift Valley fever patients are indicative of severe disease |
| Q35097103 | The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging |
| Q40174551 | The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice |
| Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
| Q34828833 | The use of NanoTrap particles as a sample enrichment method to enhance the detection of Rift Valley Fever Virus |
| Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
| Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
Search more.